Methylcobalamin for peripheral nervous system diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 20 Feb 2026: Trial registered, NCT07423390
  2. 24 Feb 2026: Trial started, NCT07423390

The trials

NCT07423390: Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy

State
Under way
Phase
Phase 3
People
326 planned
Started
24 Feb 2026
Primary completion
30 Mar 2029
Arms
Mecobalamin Prophylaxis
Results
None posted
  1. 20 Feb 2026: Trial registered
  2. 24 Feb 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Adestolmin, Methycobal, mecobalamin.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.